Crosslinking of α-synuclein by advanced glycation endproducts — an early pathophysiological step in Lewy body formation?
- 1 December 2000
- journal article
- Published by Elsevier in Journal of Chemical Neuroanatomy
- Vol. 20 (3-4), 253-257
- https://doi.org/10.1016/s0891-0618(00)00096-x
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Involvement of α-synuclein in Parkinson's disease and other neurodegenerative disordersJournal of Neural Transmission, 2000
- Amadorins: Novel Post-Amadori Inhibitors of Advanced Glycation ReactionsBiochemical and Biophysical Research Communications, 1999
- Parkinson's disease: a major hypokinetic basal ganglia disorderJournal of Neural Transmission, 1999
- Transition Metals Bind to Glycated Proteins Forming Redox Active “Glycochelates”: Implications for the Pathogenesis of Certain Diabetic ComplicationsBiochemical and Biophysical Research Communications, 1998
- α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodiesProceedings of the National Academy of Sciences, 1998
- Glutathione-dependent detoxification of α-oxoaldehydes by the glyoxalase system: involvement in disease mechanisms and antiproliferative activity of glyoxalase I inhibitorsChemico-Biological Interactions, 1998
- Alzheimer's disease – synergistic effects of glucose deficit, oxidative stress and advanced glycation endproductsJournal of Neural Transmission, 1998
- Alterations in the distribution of glutathione in the substantia nigra in Parkinson's diseaseJournal of Neural Transmission, 1997
- Interleukin-1β, interleukin-6, epidermal growth factor and transforming growth factor-α are elevated in the brain from parkinsonian patientsNeuroscience Letters, 1994
- Free radical generation by early glycation products: A mechanism for accelerated atherogenesis in diabetesBiochemical and Biophysical Research Communications, 1990